ANTI-HUMAN GLOBULIN (COOMBS) - ANVISA Registration 81034870008
Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81034870008 and manufactured by SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA. The registration is held by SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA with validity until Oct 15, 2028.
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DIAMED GMBH, ORTHO CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81034870008
25351289126201800
18520715000130
Company Information
Dates and Status
Oct 15, 2018
15/10/2028
09/18/2025 19:00:01
GLOBULINA ANTI-HUMANA (COOMBS)
ID-DC Screening II
Not specified
80020690455
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
ID-Coombs Anti-IgG
Not specified
80020690463
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
ID-DC Screening II
DIAMED GMBH
80020690455
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
ID-DAT IgG - Dilution
Not specified
80020690462
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
ID-DAT IgG1/IgG3
DIAMED GMBH
80020690454
Jul 14, 2025

